Impact of thiopurines and tumour necrosis factor antagonists on primary sclerosing cholangitis outcomes in patients with inflammatory bowel disease.
Amélie BironLaurent BeaugerieOlivier ChazouillèresJulien KirchgesnerPublished in: Alimentary pharmacology & therapeutics (2022)
Patients with PSC and IBD who are exposed to thiopurines or anti-TNF agents are not at excess risk of biliary tract cancer or liver transplantation.